PIERRE, S.D. (KELO.com) – Some critics ask why South Dakota’s Hydroxycholorquine Study should continue, what with other studies showing problems with the drug.

Sanford’s Dr. Alison Suttle says her study is totally different, focusing only on whether the drug can help healthy people not get COVID-19.

Suttle says comparing the South Dakota clinical trial to other studies is simply not ‘apples to apples.’